New York, New York, October 14, 2012 -- Corinthian Colleges Inc(NASDAQ:COCO) shares gained 3.14% and closed at $2.63 in yesterday’s session. The company will report financial results for the first quarter ended September 30, 2012, on October 31 prior to market open. The company will host a conference call at 12:00 p.m. ET (9:00 a.m. PT) on Wednesday, October 31 to review its performance and outlook.
Will COCO Move Higher After Today’s Sudden Selling Activities? Don’t Miss The Free Trend Analysis here http://beststocksdaily.com/p2/index.php?company=COCO
JA Solar Holdings Co., Ltd. (ADR)(NASDAQ:JASO) shares fell 5.16% and closed at $0.790 in yesterday’s session. The company responded to the final determination by the U.S. Department of Commerce ("DOC") on imposing anti-dumping duties on China-produced solar products. In its final decision, the DOC determined that crystalline silicon photovoltaic cells produced in China, whether or not assembled into modules, would be subject to antidumping and countervailing duties
How Should Investors Trade JASO After The Recent Momentum, Find Out Here http://beststocksdaily.com/p2/index.php?company=JASO
Affymetrix, Inc.(NASDAQ:AFFX) shares declined 2.84% and closed at $3.42 in the last trading session. The company, last week, estimated third-quarter revenue that was below expectations, as tightening academic funding worldwide reduced sales at its gene expression and eBioscience business units. The company said total third-quarter revenue would be $80 million, lower than analysts' estimates of $84.6 million.
Get Free Special Trend Analysis On AFFX Here http://beststocksdaily.com/p2/index.php?company=AFFX
YM BioSciences Inc. (USA)(NYSEAMEX:YMI) shares dropped 4.32% and closed at $1.55 in the previous trading session. The company announced that the results of its Phase I/II Study of CYT387, a JAK1/JAK2 inhibitor currently being evaluated for the treatment of myelofibrosis, have been selected by the ASH Program Committee for presentation in an Oral Session at the 2012 Annual Meeting of the American Society of Hematology to be held in Atlanta, Georgia on December 9, 2012.
Get Free Special Trend Analysis On YMI Here http://beststocksdaily.com/p2/index.php?company=YMI
Hemispherx BioPharma, Inc(NYSEAMEX:HEB) shares fell 1.97% and closed at $0.696 in yesterday’s session. The company, this month, announced that the Company has filed with ANMAT (Administracion Nacional de Medicamentos, Alimentos y Tecnologia Medica), the agency responsible for the national regulation of drugs, foods and medical technology in Argentina, an amended NDA for the use of its natural-source Alferon N Injection in patients with chronic hepatitis C who have become refractory to recombinant interferon as a result of the appearance of neutralizing antibodies (NABs) against recombinant interferon.
Get Free Special Trend Analysis On HEB Here http://beststocksdaily.com/p2/index.php?company=HEB
About Beststocksdaily
Beststocksdaily’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily’s instant stock news on Major Gainers, Hot Stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.
Disclaimer:
The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
CONTACT:
Brian Burr
Beststocksdaily
1419 Westwood Blvd Los Angeles, CA
90024-4911
staff@beststocksdaily.com
www.beststocksdaily.com
SOURCE BestStocksDaily.com